REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT

NCT01762592 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped new sponsor

Conditions

Renal Cell Carcinoma
Kidney Cancer

Interventions

DRUG: Iodine (124I) Girentuximab

Sponsor

Heidelberg Pharma AG